EP3260124
METHODS TO REDUCE ADVERSE EVENTS CAUSED BY PHARMACEUTICAL PREPARATIONS COMPRISING PLASMA DERIVED PROTEINS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
14.5.2012EP published:
12.7.2023EP application number:
17181203.5
EPO information:
European Patent Register
Max expiry date:
13.5.2032
Title in English:
METHODS TO REDUCE ADVERSE EVENTS CAUSED BY PHARMACEUTICAL PREPARATIONS COMPRISING PLASMA DERIVED PROTEINSLanguage of the patent:
English
Timeline
Today
14.5.2012EP application
12.7.2023EP Publication
Owner
Name:
CSL Behring GmbHAddress:
Emil-von-Behring-Strasse 76, 35041 Marburg, DE
Inventor
Name:
Schulte, StefanAddress:
35043 Marburg, DE
Name:
Kalina, UweAddress:
35041 Marburg, DE
Name:
Moses, MichaelAddress:
61279 Graevenwiesbach, DE
Name:
Feussner, AnnetteAddress:
35043 Marburg, DE
Priority
Number:
11165869Date:
12.5.2011Country:
EP
Number:
201161487205 PDate:
17.5.2011Country:
US
Classification
Categories:
A61K 38/38, A61K 31/727, A61K 35/16, A61K 38/57, A61P 1/00, A61P 7/02, A61P 9/06, A61P 9/12, A61P 11/08